Literature DB >> 8202415

Antibiotic-induced diarrhea and pseudomembranous colitis.

N F Jacobs1.   

Abstract

Pseudomembranous colitis is commonly associated with the use of antibiotics but may follow administration of other drugs and has occurred in patients who have not received any medication. Cases related to antibiotic administration are thought to be due to changes in normal intestinal flora that allow overgrowth of Clostridium difficile and elaboration of toxin. Clusters of cases in hospitals suggest nosocomial transmission of the bacteria. The stool cytotoxin assay is the most specific test for pseudomembranous colitis. Oral vancomycin (Vancocin) is preferred for the treatment of severe cases. It is recommended that hospital personnel caring for patients infected with C difficile wear gloves and wash their hands carefully after contact.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8202415     DOI: 10.1080/00325481.1994.11945865

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  5 in total

Review 1.  Drug-induced Clostridium difficile-associated disease.

Authors:  M L Job; N F Jacobs
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

2.  Clostridium difficile infection as a cause of severe sepsis.

Authors:  S E Lowenkron; J Waxner; P Khullar; J S Ilowite; M S Niederman; A M Fein
Journal:  Intensive Care Med       Date:  1996-09       Impact factor: 17.440

3.  Practical considerations in the use of outpatient antimicrobial therapy for musculoskeletal infections.

Authors:  Camelia E Marculescu; Elie F Berbari; J Robert Cantey; Douglas R Osmon
Journal:  Mayo Clin Proc       Date:  2012-01       Impact factor: 7.616

4.  The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease?

Authors:  Justyna Bien; Vindhya Palagani; Przemyslaw Bozko
Journal:  Therap Adv Gastroenterol       Date:  2013-01       Impact factor: 4.409

5.  Outcomes in Patients with SARS-CoV-2 and Clostridioides difficile Coinfection.

Authors:  Kanika Sehgal; Hind J Fadel; Aaron J Tande; Darrell S Pardi; Sahil Khanna
Journal:  Infect Drug Resist       Date:  2021-04-28       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.